|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-thalassemia
1 EA 647 Center of Research and Innovation on Sports, University of Lyon 1, Villeurbanne, France
2 Kosair Childrens Hospital Research Institute, University of Louisville, Louisville, Kentucky, United States
3 National Institute of Youth and Health, Yaounde, Cameroon
4 UMR 5123 Integrative cellular and molecular physiology, University of Lyon 1, Villeurbanne, France
5 Molecular pathology of hemoglobin, Edouard Herriot Hospital, Lyon, France
6 Laboratory of Biochemicals, Medicine Faculty, University of Yaounde 1, Yaounde, Cameroon
* To whom correspondence should be addressed. E-mail: cyril.martin{at}univ-lyon.fr.
The aim of the study was to examine the effects of exercise on vascular cell adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1) in sickle cell trait (SCT) athletes with or without
-thalassemia. Six athletes with SCT, 7 athletes with both SCT and
-thalassemia (SCTAT) and 7 control athletes (CONT) performed an incremental and maximal test on cycloergometer. Levels of soluble sICAM-1, sVCAM-1 were assessed at rest, immediately after the end of exercise and one, two and twenty-four hours after exercise. Although, CONT and SCTAT groups exhibited similar basal plasma levels of inflammatory and adhesion molecules, SCT group had higher sVCAM-1 basal concentrations. Incremental exercise resulted in a significant increase of sVCAM-1 in all subjects, which remained elevated only in the SCT group during the recovery period. In conclusion, as sVCAM-1 increased with exercise and during the recovery period, our findings support the concept that SCT athletes might be at risk for microcirculatory disturbances and adhesive phenomena developing at rest and several hours after exercise. Alpha-thalassemia might be considered protective among exercising SCT subjects.
This article has been cited by other articles:
![]() |
Rebuttal from Prof. Le Gallais J Appl Physiol, December 1, 2007; 103(6): 2140 - 2141. [Full Text] [PDF] |
||||
![]() |
O. K. Baskurt, H. J. Meiselman, and M. F. Bergeron Sickle cell trait should be considered asymptomatic and as a benign condition during physical activity J Appl Physiol, December 1, 2007; 103(6): 2142 - 2142. [Full Text] [PDF] |
||||
![]() |
D. Le Gallais, J. Lonsdorfer, P. Bogui, and S. Fattoum Last Word on Point:Counterpoint "Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity" J Appl Physiol, December 1, 2007; 103(6): 2143 - 2143. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |